In-situ tumor vaccination by percutaneous ablative therapy and its synergy with immunotherapeutics: An update on combination therapy
Article in Frontiers in Immunology (March 2023)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Radiofrequency ablation in combination with CD73 inhibitor AB680 reduces tumor growth and enhances anti-tumor immunity in a syngeneic model of pancreatic ductal adenocarcinoma
Article in Frontiers in Oncology (September 2022)
Radiofrequency ablation remodels the tumor microenvironment and promotes systemic immunomodulation in pancreatic cancer
Preprint in bioRxiv (January 2022)